 Christian Herzog
Concepts (184)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metalloendopeptidases | 7 | 2015 | 70 | 1.870 |
Why?
| | Acute Kidney Injury | 5 | 2025 | 392 | 1.030 |
Why?
| | Cisplatin | 6 | 2025 | 285 | 0.990 |
Why?
| | Glomerulonephritis, Membranous | 5 | 2023 | 28 | 0.880 |
Why?
| | Metalloproteases | 1 | 2018 | 10 | 0.610 |
Why?
| | Kidney | 5 | 2025 | 723 | 0.560 |
Why?
| | Interleukin-1 | 2 | 2009 | 105 | 0.530 |
Why?
| | Membrane Glycoproteins | 2 | 2015 | 242 | 0.490 |
Why?
| | Inflammation | 2 | 2018 | 644 | 0.490 |
Why?
| | Basement Membrane | 1 | 2015 | 18 | 0.480 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2014 | 11 | 0.440 |
Why?
| | ADAM Proteins | 1 | 2014 | 21 | 0.440 |
Why?
| | Cell Membrane | 2 | 2014 | 242 | 0.430 |
Why?
| | Membrane Proteins | 2 | 2023 | 337 | 0.410 |
Why?
| | Autophagy | 2 | 2012 | 199 | 0.410 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2012 | 10 | 0.400 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 16 | 0.390 |
Why?
| | Kidney Diseases | 3 | 2019 | 231 | 0.370 |
Why?
| | Lupus Nephritis | 2 | 2023 | 18 | 0.370 |
Why?
| | Antineoplastic Agents | 4 | 2015 | 1221 | 0.360 |
Why?
| | Kidney Tubules | 2 | 2008 | 62 | 0.330 |
Why?
| | Sepsis | 2 | 2011 | 234 | 0.320 |
Why?
| | Interleukin-1beta | 2 | 2011 | 87 | 0.310 |
Why?
| | Protein Precursors | 1 | 2009 | 42 | 0.310 |
Why?
| | Animals | 14 | 2025 | 13507 | 0.280 |
Why?
| | Hydroxamic Acids | 4 | 2015 | 38 | 0.280 |
Why?
| | Amino Acid Sequence | 4 | 2018 | 574 | 0.270 |
Why?
| | Mice | 11 | 2025 | 5958 | 0.260 |
Why?
| | Autoantibodies | 3 | 2023 | 121 | 0.260 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 1 | 2025 | 17 | 0.230 |
Why?
| | Mice, Knockout | 4 | 2025 | 910 | 0.220 |
Why?
| | Glutathione Transferase | 5 | 2001 | 175 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 1900 | 0.190 |
Why?
| | Carcinogens | 3 | 2014 | 193 | 0.180 |
Why?
| | Cytokines | 2 | 2018 | 626 | 0.170 |
Why?
| | Apoptosis | 3 | 2014 | 1121 | 0.170 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2020 | 66 | 0.170 |
Why?
| | Isoenzymes | 4 | 2001 | 167 | 0.160 |
Why?
| | Glomerulonephritis | 1 | 2019 | 17 | 0.160 |
Why?
| | Leukocytes | 3 | 2013 | 60 | 0.150 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 69 | 0.150 |
Why?
| | Proteolysis | 1 | 2018 | 102 | 0.150 |
Why?
| | Humans | 18 | 2025 | 52593 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2009 | 42 | 0.130 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 773 | 0.130 |
Why?
| | Immunoglobulin G | 3 | 2023 | 195 | 0.130 |
Why?
| | Recombinant Proteins | 2 | 2009 | 496 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2025 | 1486 | 0.120 |
Why?
| | Protein Transport | 1 | 2015 | 183 | 0.110 |
Why?
| | Calcium Ionophores | 1 | 2014 | 2 | 0.110 |
Why?
| | Ionomycin | 1 | 2014 | 4 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2014 | 45 | 0.110 |
Why?
| | Hepatitis A Antibodies | 1 | 2014 | 1 | 0.110 |
Why?
| | Hepatitis A Vaccines | 1 | 2014 | 3 | 0.110 |
Why?
| | Hepatitis A | 1 | 2014 | 5 | 0.110 |
Why?
| | Molecular Biology | 1 | 2014 | 27 | 0.110 |
Why?
| | Genotype | 1 | 2015 | 571 | 0.110 |
Why?
| | Caspases | 1 | 2014 | 102 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2014 | 232 | 0.100 |
Why?
| | Male | 7 | 2025 | 26863 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2014 | 118 | 0.100 |
Why?
| | Mass Spectrometry | 2 | 2023 | 293 | 0.100 |
Why?
| | Cathepsin B | 1 | 2012 | 6 | 0.100 |
Why?
| | Calpain | 1 | 2012 | 26 | 0.100 |
Why?
| | Microtubule-Associated Proteins | 1 | 2012 | 64 | 0.100 |
Why?
| | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 3 | 2001 | 10 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 87 | 0.100 |
Why?
| | Lysosomes | 1 | 2012 | 78 | 0.090 |
Why?
| | Receptors, Phospholipase A2 | 2 | 2023 | 14 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2013 | 215 | 0.090 |
Why?
| | Renal Circulation | 1 | 2011 | 56 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 63 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 1006 | 0.080 |
Why?
| | Neoplasms | 1 | 2020 | 1308 | 0.080 |
Why?
| | Polycyclic Compounds | 2 | 2001 | 8 | 0.080 |
Why?
| | Binding Sites | 4 | 2005 | 377 | 0.080 |
Why?
| | Proteins | 1 | 2012 | 354 | 0.080 |
Why?
| | Protease Inhibitors | 1 | 2009 | 59 | 0.080 |
Why?
| | Kidney Cortex | 1 | 2009 | 23 | 0.080 |
Why?
| | Prognosis | 2 | 2025 | 2118 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2012 | 1588 | 0.070 |
Why?
| | Proteasome Inhibitors | 1 | 2009 | 105 | 0.070 |
Why?
| | Blotting, Western | 2 | 2009 | 593 | 0.070 |
Why?
| | Microvilli | 1 | 2007 | 6 | 0.070 |
Why?
| | Receptors, Virus | 1 | 2007 | 26 | 0.070 |
Why?
| | Catalase | 2 | 1999 | 74 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 173 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2007 | 125 | 0.070 |
Why?
| | Rats | 2 | 2013 | 3203 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 252 | 0.060 |
Why?
| | Scrapie | 1 | 2006 | 1 | 0.060 |
Why?
| | Prion Diseases | 1 | 2006 | 6 | 0.060 |
Why?
| | Acute Disease | 1 | 2007 | 387 | 0.060 |
Why?
| | Mitochondria | 1 | 2009 | 425 | 0.060 |
Why?
| | Ions | 1 | 2005 | 32 | 0.060 |
Why?
| | Caspase 1 | 1 | 2005 | 22 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 96 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2005 | 63 | 0.060 |
Why?
| | Time Factors | 3 | 2008 | 3000 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 137 | 0.060 |
Why?
| | Glycosylation | 1 | 2005 | 104 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2005 | 130 | 0.060 |
Why?
| | Alleles | 3 | 2000 | 278 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2006 | 253 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 803 | 0.060 |
Why?
| | Epoxy Compounds | 2 | 2000 | 47 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2023 | 50 | 0.050 |
Why?
| | Antigen-Antibody Complex | 1 | 2023 | 35 | 0.050 |
Why?
| | Cell Line | 1 | 2005 | 1033 | 0.050 |
Why?
| | Aged | 3 | 2025 | 10191 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 952 | 0.050 |
Why?
| | Disease Progression | 1 | 2025 | 873 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 27 | 0.050 |
Why?
| | Cardiac Surgical Procedures | 1 | 2025 | 328 | 0.050 |
Why?
| | Glomerular Basement Membrane | 1 | 2021 | 10 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2025 | 1037 | 0.050 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2021 | 29 | 0.040 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2021 | 56 | 0.040 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 58 | 0.040 |
Why?
| | Phenanthrenes | 1 | 2000 | 13 | 0.040 |
Why?
| | Proteoglycans | 1 | 2021 | 87 | 0.040 |
Why?
| | Female | 5 | 2025 | 28262 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2020 | 10 | 0.040 |
Why?
| | Thrombospondins | 1 | 2020 | 10 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 1999 | 170 | 0.040 |
Why?
| | Autoantigens | 1 | 2020 | 52 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 58 | 0.040 |
Why?
| | Angiotensin II | 1 | 2021 | 162 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 182 | 0.040 |
Why?
| | Kidney Glomerulus | 1 | 2019 | 43 | 0.040 |
Why?
| | Xenobiotics | 1 | 1999 | 31 | 0.040 |
Why?
| | Carcinogens, Environmental | 1 | 1999 | 22 | 0.040 |
Why?
| | Water | 1 | 1999 | 82 | 0.040 |
Why?
| | DNA Adducts | 1 | 1999 | 79 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2001 | 97 | 0.040 |
Why?
| | DNA Damage | 1 | 1999 | 307 | 0.030 |
Why?
| | Glutathione S-Transferase pi | 3 | 2000 | 25 | 0.030 |
Why?
| | Middle Aged | 2 | 2025 | 13096 | 0.030 |
Why?
| | Models, Molecular | 3 | 2001 | 352 | 0.030 |
Why?
| | Substrate Specificity | 3 | 2000 | 196 | 0.030 |
Why?
| | Antirheumatic Agents | 1 | 2014 | 39 | 0.030 |
Why?
| | Methotrexate | 1 | 2014 | 77 | 0.030 |
Why?
| | Structure-Activity Relationship | 3 | 2000 | 405 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2014 | 123 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2025 | 6671 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2014 | 1202 | 0.020 |
Why?
| | LLC-PK1 Cells | 1 | 2009 | 10 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2009 | 57 | 0.020 |
Why?
| | Crystallography, X-Ray | 2 | 1999 | 156 | 0.020 |
Why?
| | Protein Conformation | 2 | 1999 | 179 | 0.020 |
Why?
| | Swine | 1 | 2009 | 427 | 0.020 |
Why?
| | Prospective Studies | 1 | 2014 | 2457 | 0.020 |
Why?
| | Heme | 2 | 1999 | 21 | 0.020 |
Why?
| | Aspartic Acid | 1 | 2006 | 45 | 0.020 |
Why?
| | Cattle | 1 | 2006 | 207 | 0.010 |
Why?
| | Catalysis | 1 | 2001 | 89 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 206 | 0.010 |
Why?
| | Isomerism | 1 | 2000 | 24 | 0.010 |
Why?
| | Base Sequence | 1 | 2001 | 637 | 0.010 |
Why?
| | Molecular Structure | 1 | 2000 | 315 | 0.010 |
Why?
| | Alkanesulfonic Acids | 1 | 1999 | 10 | 0.010 |
Why?
| | Crystallization | 1 | 1999 | 33 | 0.010 |
Why?
| | Genetic Variation | 1 | 2000 | 230 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1999 | 102 | 0.010 |
Why?
| | NADP | 1 | 1999 | 23 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1999 | 80 | 0.010 |
Why?
| | Morpholines | 1 | 1999 | 65 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 44 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1999 | 44 | 0.010 |
Why?
| | Valine | 1 | 1999 | 57 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 1545 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1999 | 175 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 448 | 0.010 |
Why?
| | Transfection | 1 | 1999 | 369 | 0.010 |
Why?
| | Air Pollutants | 1 | 1999 | 75 | 0.010 |
Why?
| | Glutathione | 1 | 1999 | 306 | 0.010 |
Why?
| | Adult | 1 | 2014 | 14170 | 0.010 |
Why?
| | Brain | 1 | 2006 | 1325 | 0.010 |
Why?
| | Kinetics | 1 | 1997 | 622 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 1999 | 528 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1999 | 331 | 0.010 |
Why?
| | Peroxidases | 1 | 1995 | 8 | 0.010 |
Why?
| | Protein Denaturation | 1 | 1995 | 16 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 115 | 0.010 |
Why?
|
|
Herzog's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|